Manufacturer
Galderma
Contents
Fluocinolone acetonide 0.01%, hydroquinone 4%, tretinoin 0.05%
Indication
Short-term treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens.
Instruction
Apply once daily at night, at least 30 min before bedtime, on hyperpigmented areas of melasma including about ½ inch of normal skin surrounding the affected areas.
Drug interaction
-
Malaysia
